See more : Hunan Zhongke Electric Co., Ltd. (300035.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of TATA Health International Holdings Limited (1255.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TATA Health International Holdings Limited, a leading company in the Apparel – Footwear & Accessories industry within the Consumer Cyclical sector.
- PT Uni-Charm Indonesia Tbk (UCID.JK) Income Statement Analysis – Financial Results
- Union Bridge Holdings Limited (UGHL) Income Statement Analysis – Financial Results
- Sino American Oil Company (OILY) Income Statement Analysis – Financial Results
- Webcentral Limited (MLBEF) Income Statement Analysis – Financial Results
- Carrianna Group Holdings Company Limited (0126.HK) Income Statement Analysis – Financial Results
TATA Health International Holdings Limited (1255.HK)
Industry: Apparel - Footwear & Accessories
Sector: Consumer Cyclical
Website: https://www.s-culture.com
About TATA Health International Holdings Limited
TATA Health International Holdings Limited, an investment holding company, engages in the trading of footwear and healthcare products, and the provision of financial services and online medical services. It operates through Trading of Footwear Products, Trading of Healthcare Products, Financial Services, and Online Medical Services segments. The company is involved in the wholesale and retail of footwear products. It offers footwear products of various brands comprising Clarks and Josef Seibel brands. As of December 31, 2021, the company operated 29 retail outlets in Hong Kong and 1 retail outlet in Macau. In addition, it provides securities advisory services, investment management services, and corporate finance advisory services. It has operations in Hong Kong, Australia, Macau, and Mainland China. The company was formerly known as S. Culture International Holdings Limited and changed its name to TATA Health International Holdings Limited in November 2020. TATA Health International Holdings Limited was founded in 1974 and is headquartered in Kwai Chung, Hong Kong.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 144.61M | 160.93M | 155.36M | 341.77M | 358.01M | 483.72M | 562.47M | 561.03M | 590.54M | 550.13M | 505.29M |
| Cost of Revenue | 30.66M | 56.21M | 121.08M | 142.30M | 137.50M | 230.88M | 241.95M | 213.53M | 218.84M | 199.80M | 178.33M |
| Gross Profit | 113.94M | 104.72M | 34.28M | 199.47M | 220.51M | 252.84M | 320.53M | 347.49M | 371.70M | 350.34M | 326.96M |
| Gross Profit Ratio | 78.80% | 65.07% | 22.07% | 58.36% | 61.59% | 52.27% | 56.99% | 61.94% | 62.94% | 63.68% | 64.71% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 82.23M | 97.26M | 101.07M | 99.09M | 72.76M | 82.15M | 136.10M | 139.80M | 146.07M | 122.05M | 104.88M |
| Selling & Marketing | 61.79M | 65.67M | 82.04M | 137.24M | 147.37M | 212.96M | 218.40M | 220.85M | 212.97M | 201.24M | 188.14M |
| SG&A | 144.02M | 162.92M | 183.12M | 236.32M | 220.13M | 295.11M | 354.50M | 360.65M | 359.04M | 323.28M | 293.02M |
| Other Expenses | 0.00 | -525.00K | -12.68M | 691.00K | 260.00K | -353.00K | 916.00K | 916.00K | 908.00K | 84.00K | -611.00K |
| Operating Expenses | 140.80M | 162.40M | 170.44M | 236.32M | 220.13M | 294.76M | 354.20M | 360.44M | 358.77M | 323.08M | 292.41M |
| Cost & Expenses | 174.67M | 218.61M | 291.52M | 378.62M | 357.63M | 525.64M | 596.15M | 573.98M | 577.61M | 522.88M | 470.74M |
| Interest Income | 1.45M | 1.19M | 563.00K | 305.00K | 37.00K | 33.00K | 99.00K | 577.00K | 778.00K | 181.00K | 15.00K |
| Interest Expense | 2.49M | 2.76M | 3.57M | 2.86M | 1.64M | 3.18M | 3.71M | 3.06M | 2.04M | 1.93M | 1.75M |
| Depreciation & Amortization | 12.02M | 13.76M | 24.41M | 32.32M | 3.70M | 8.07M | 10.85M | 13.15M | 14.23M | 12.24M | 10.76M |
| EBITDA | 19.01M | -52.05M | -145.48M | -32.26M | 4.08M | -31.69M | -21.83M | -151.00K | 28.36M | 40.07M | 42.63M |
| EBITDA Ratio | 13.15% | -26.89% | -72.47% | -8.40% | 1.26% | -5.48% | -4.02% | -0.03% | 4.80% | 7.28% | 9.05% |
| Operating Income | -30.06M | -57.03M | -137.01M | -61.04M | 824.00K | -34.57M | -33.46M | -13.33M | 14.13M | 27.83M | 34.98M |
| Operating Income Ratio | -20.79% | -35.44% | -88.19% | -17.86% | 0.23% | -7.15% | -5.95% | -2.38% | 2.39% | 5.06% | 6.92% |
| Total Other Income/Expenses | 34.17M | -11.46M | -35.68M | -30.60M | 6.20M | -617.00K | -2.72M | -3.21M | -809.00K | -6.30M | -4.43M |
| Income Before Tax | 4.10M | -69.14M | -172.68M | -67.45M | 6.58M | -42.93M | -37.31M | -16.36M | 12.12M | 20.96M | 30.12M |
| Income Before Tax Ratio | 2.84% | -42.97% | -111.15% | -19.73% | 1.84% | -8.88% | -6.63% | -2.92% | 2.05% | 3.81% | 5.96% |
| Income Tax Expense | 898.00K | 1.31M | 396.00K | -544.00K | 498.00K | 511.00K | -2.71M | 13.00K | 3.09M | 4.46M | 5.04M |
| Net Income | 9.61M | -70.45M | -173.08M | -66.90M | 6.09M | -43.44M | -34.61M | -16.37M | 9.04M | 16.50M | 25.08M |
| Net Income Ratio | 6.65% | -43.78% | -111.40% | -19.57% | 1.70% | -8.98% | -6.15% | -2.92% | 1.53% | 3.00% | 4.96% |
| EPS | 0.04 | -0.30 | -0.81 | -0.31 | 0.03 | -0.22 | -0.17 | -0.08 | 0.05 | 0.09 | 0.17 |
| EPS Diluted | 0.04 | -0.30 | -0.81 | -0.31 | 0.03 | -0.22 | -0.17 | -0.08 | 0.05 | 0.09 | 0.17 |
| Weighted Avg Shares Out | 242.85M | 232.02M | 214.00M | 214.00M | 211.74M | 200.00M | 200.00M | 200.00M | 200.00M | 173.84M | 150.00M |
| Weighted Avg Shares Out (Dil) | 242.85M | 232.02M | 214.00M | 214.00M | 211.74M | 200.00M | 200.00M | 200.00M | 200.00M | 173.84M | 150.00M |
Source: https://incomestatements.info
Category: Stock Reports